NCT05291182 2024-02-02
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
Clinical Trials
15 trialsNCT06006793 2023-09-01
A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT05498519 2023-05-11
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT05805956 2023-04-10
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT05644509 2022-12-09
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Unknown
NCT05205408 2022-11-29
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Bengbu Medical University
Phase 1 Unknown
NCT05515185 2022-08-25
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors
The First People's Hospital of Lianyungang
Phase EARLY_PHASE1 Unknown
NCT05228119 2022-05-09
A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Unknown
NCT04579978 2022-05-05
TIME
Sunnybrook Health Sciences Centre
Unknown
NCT05202561 2022-03-23
A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Bengbu Medical University
Phase 1 Unknown
NCT05122572 2022-01-20
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Wuxi People's Hospital
Phase 1 Unknown
NCT04282278 2021-12-10
Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor
Hebei Medical University Fourth Hospital
Phase 2 Unknown
NCT05020119 2021-08-25
Neoantigen-expanded Autologous Immune Cell Therapy
Chang Gung Memorial Hospital
Phase 1 Unknown
NCT04337463 2021-05-17
ATG-008 Combined With Toripalimab in Advanced Solid Tumors
Sichuan University
Phase 1/2 Unknown
NCT03929965 2019-04-29
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Shanghai Changzheng Hospital
Phase NA Unknown